Literature DB >> 18302012

Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.

Yuan Gao1, Lin-Xuan Song, Miao-Na Jiang, Guang-Yan Ge, Yu-Jie Jia.   

Abstract

AIMS: The aim of this research is to study the effects of traditional Chinese medicine on endotoxin and its receptors in rats with nonalcoholic steatohepatitis (NASH).
METHODS: Fifty-six SD rats were divided into seven groups. All the animals were fed high fatty diet for 12 weeks. Rats with non-alcoholic steatohepatitis (NASH) were treated with traditional Chinese medicine according to low-dose, middle-dose, high-dose and Lipitor from fifth week. All rats were killed at the end of 12th week. The liver pathology changes were observed under light microscope. The levels of serum lipoid, alanine aminotransferase (ALT), endotoxin (ET), tumor necrosis factor-alpha (TNF-alpha) and interleukine-1beta (IL-1beta) were determined. The expressions of CD14 and nuclear transcriptional factor kappaB (NF-kappaB) were observed by immunohistochemistry. The expressions of lipopolysaccharide binding protein (LBP), toll-like receptor-4 (TLR-4), myeloid differentiation-2 (MD-2) and induced nitric oxide synthase (iNOS) mRNA were detected by the reverse transcription polymerase chain reaction (RT-PCR).
RESULTS: The levels of serum endotoxin in the middle dose group (0.0225 +/- 0.0112 EU/l) were lower than those in high fatty diet model group (0.2249 +/- 0.0982 EU/l) at 12th week, the difference was significant (P < 0.01). In the middle dose group, mean values of serum TNF-alpha and IL-1beta levels decreased dramatically (1.604 +/- 0.302 ng/ml and 0.052 +/- 0.024 ng/ml) compared with those in the high fatty diet model group (4.029 +/- 1.180 ng/ml and 14.944 +/- 0.491 ng/ml; P < 0.01 and P < 0.01). The expressions of CD14 and NF-kappaB in the middle dose group decreased compared with those in the high fatty diet model group. The expressions of LBP mRNA (0.284 +/- 0.105) and TLR-4 mRNA (0.290 +/- 0.123) in the middle dose group down regulated compared with those in the high fatty diet model group (1.060 +/- 0.158 and 1.261 +/- 0.368; P < 0.01 and P < 0.01). In the middle dose group MD-2 and iNOS gene expressions were 0.132 +/- 0.058 and 0.164 +/- 0.061, respectively, which were significantly lower compared with the high fatty diet model group (0.795 +/- 0.294 and 1.029 +/- 0.388; P < 0.01 and P < 0.01).
CONCLUSIONS: The mechanism of non-alcoholic steatohepatitis (NASH) maybe related to increasing the levels of serum endotoxin, upregulating endotoxin receptors of hepatic tissue and enhancing liver inflammatory injury. Traditional Chinese medicine is a good treatment for non-alcoholic steatohepatitis (NASH). It can produce a marked effect via relieving LPS-induced liver injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18302012     DOI: 10.1007/s10753-008-9057-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

Review 1.  Cytokines in alcoholic and nonalcoholic steatohepatitis.

Authors:  H Tilg; A M Diehl
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

2.  Adhesion molecule and proinflammatory cytokine gene expression in hepatic sinusoidal endothelial cells following cecal ligation and puncture.

Authors:  R Q Wu; Y X Xu; X H Song; L J Chen; X J Meng
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

4.  Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M.

Authors:  Khalid A Tazi; Jean-Jacques Quioc; Véronique Saada; Annie Bezeaud; Didier Lebrec; Richard Moreau
Journal:  J Hepatol       Date:  2006-03-31       Impact factor: 25.083

Review 5.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

6.  Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes.

Authors:  Min Jeong Song; Kang Ho Kim; Jeong Min Yoon; Jae Bum Kim
Journal:  Biochem Biophys Res Commun       Date:  2006-06-06       Impact factor: 3.575

7.  Role of plasma, lipopolysaccharide-binding protein, and CD14 in response of mouse peritoneal exudate macrophages to endotoxin.

Authors:  D Heumann; Y Adachi; D Le Roy; N Ohno; T Yadomae; M P Glauser; T Calandra
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 8.  Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management.

Authors:  Piero Portincasa; Ignazio Grattagliano; Vincenzo O Palmieri; Giuseppe Palasciano
Journal:  Clin Biochem       Date:  2005-03       Impact factor: 3.281

9.  Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.

Authors:  Yong-Han Paik; Robert F Schwabe; Ramón Bataller; Maria P Russo; Christian Jobin; David A Brenner
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

10.  MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.

Authors:  R Shimazu; S Akashi; H Ogata; Y Nagai; K Fukudome; K Miyake; M Kimoto
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more
  5 in total

1.  Effects of Ganfukang on expression of connective tissue growth factor and focal adhesion kinase/protein kinase B signal pathway in hepatic fibrosis rats.

Authors:  Kun Zhang; Miao-na Jiang; Cai-hua Zhang; Cong Li; Yu-jie Jia
Journal:  Chin J Integr Med       Date:  2013-08-29       Impact factor: 1.978

2.  Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

Authors:  Ahmed Abu Shanab; Paul Scully; Orla Crosbie; Martin Buckley; Liam O'Mahony; Fergus Shanahan; Sanaa Gazareen; Eileen Murphy; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

3.  CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy.

Authors:  Daisuke Satoh; Takahito Yagi; Takeshi Nagasaka; Susumu Shinoura; Yuzo Umeda; Ryuichi Yoshida; Masashi Utsumi; Takehiro Tanaka; Hiroshi Sadamori; Toshiyoshi Fujiwara
Journal:  World J Hepatol       Date:  2013-04-27

4.  Analysis of Therapeutic Effect of Ilex hainanensis Merr. Extract on Nonalcoholic Fatty Liver Disease through Urine Metabolite Profiling by Ultraperformance Liquid Chromatography/Quadrupole Time of Flight Mass Spectrometry.

Authors:  Jing-Jing Li; Jie Yang; Wei-Xi Cui; Xiao-Qing Chen; Gang-Ling Chen; Xiao-Dong Wen; Qiang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-27       Impact factor: 2.629

5.  Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.

Authors:  Yu Wang; Jian-Yun Li; Min Han; Wen-Long Wang; Yun-Zhang Li
Journal:  Lipids Health Dis       Date:  2015-08-06       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.